US FDA approves Daiichi Sankyo's therapy to treat breast cancer
15/12/2025 18:37
Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved Daiichi Sankyo's 4568.T therapy in combination with Roche's ROG.S drug for the first-line treatment of patients with a type of breast cancer, the regulator said on Monday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Alan Barona) ((siddhi.mahatole@thomsonreuters.com;))